Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection

Journal of Medical Virology

Volumn 78, Issue 11, 2006, Pages 1449-1451

  Navalpotro, David ^a   Gimeno, Concepción ^a,b   Navarro, David ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Heterologous IgMs; Human herpesvirus type 6; Human parvovirus B19; IgG avidity test; Measles virus; Serum DNA PCR

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS DNA;

ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; MALE; MEASLES; MEASLES VIRUS; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; RASH; SCHOOL CHILD; SEROLOGY; SUPERINFECTION; VIRUS DETECTION;

ANTIBODIES, VIRAL; CHILD; DNA, VIRAL; ERYTHEMA INFECTIOSUM; EXANTHEMA SUBITUM; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOGLOBULIN M; MALE; MEASLES VIRUS; PARVOVIRUS B19, HUMAN;

HUMAN HERPESVIRUS 6; MEASLES VIRUS; PARVOVIRUS;

EID: 33749581297     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20715     Document Type: Article

References (14)

1. Alberola J, Tamarit A, Igual R, Navarro D. 2000. Early neutralizing and glycoprotein B (gB)-specific antibody responses to human cytomegalovirus (HCMV) in immunocompetent individuals with distinct clinical presentations of primary HCMV infection. J Clin Virol 16:113-122.
2. Bruu AL, Nordbo SA. 1995. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19. J Clin Microbiol 33:1363-1365.
3. Cohen BJ, Shirley JA. 1985. Dual infection with rubella and human parvovirus. Lancet ii:662-663.
4. Dietz V, Rota J, Izurieta H, Carrasco P, Bellini W. 2004. The laboratory confirmation of suspected measles cases in settings of low measles transmission: Conclusions from the experience in the Americas. Bull WHO 82:852-857.
5. Donovan SM. 1997. Filter-positive results of an enzyme immunoassay for rubella IgM in a case of measles. Clin Infect Dis 24:271-272.
6. Gallinella G, Zuffi E, Gentilomi G, Manaresi E, Venturoli S, Bonvicini F, Cricca M, Zerbini M, Musian M. 2003. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases. J Med Virol 71:135-139.
7. Jensen IP, Vestergaard BF. 1997. Assessment of the specificity of a commercial human parvovirus B19 IgM assay. Clin Diagn Virol 7:133-137.
8. Kurtz JB, Anderson MJ. 1985. Cross-reactions in rubella and parvovirus specific IgM Tests. Lancet ii:1356.
9. Lindblom A, Isa A, Norbeck O, Wolf S, Johansson S, Broliden K, Tolfvenstam T. 2005. Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 41:1201-1203.
10. Navalpotro D, Gimeno C, Navarro D. 2006. PCR detection of viral DNA in serum as an ancillary analysis for the diagnosis of acute mononucleosis-like syndrome due to human cytomegalovirus (HCMV) in immunocompetent patients. J Clin Virol 35:193-196.
11. Nobutoki T, Hori H, Higashigawa M, Azuma E, Sakurai M, Yoshizumi T, Nunoue T. 1996. A case of prolonged human parvovirus B19 DNA-emia associated with polyclonal B cell activation. Acta Paed Jap 38:348-351.
12. Schwarz TF, Roggendorf M, Deinhart F. 1988. Human parvovirus B19: ELISA and immunoblot assays. J Virol Methods 20:155-168.
13. Söderlund M, Brown C, Cohen J, Hedman K. 1995. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 171:710-713.
14. Thomas HI, Barret E, Hesketh LM, Wynne A, Morgan-Capner P. 1999. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J Clin Virol 14:107-118.